ArticleEpilepsia2026
Insulin-like growth factor 1 receptor correlates with verbal memory in ILAE type 2 hippocampal sclerosis.
Article in Epilepsia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
objectiveLong-term memory deficits are often seen in patients with temporal lobe epilepsy (TLE). Recently, studies showed that patients with hippocampal sclerosis (HS) type 2, which presents with severe neuron loss in CA1 only, performed within the normal range. However, up to 30% of HS type 2 cases have memory deficits. As insulin-like growth factor 1 (IGF-1) is related to neurogenesis and memory performance, we sought to investigate a possible link between the expression of IGF-1 receptor (IGF-1R) and verbal memory performance among patients with HS type 2.
methodsWe selected 21 patients with left-side TLE and HS type 2. Based on presurgical neuropsychological assessment, we divided the patients into a group with normal long-term verbal memory (Preserved group, n = 15) and another with memory deficit (Deficit group, n = 6). To classify the patients, we used performance on the late recall subitems in the Logical Memory test of the Wechsler Memory Scale and late recall in Rey Auditory Verbal Learning Test (RAVLT). Coronal hippocampal sections at the body level were submitted to immunohistochemistry for NeuN and IGF-1R to evaluate neuron density and IGF-1R expression, respectively.
resultsPatients with preserved memory had the same clinical characteristics as those with memory deficit. The groups had no difference on the short-term subitem of Logical Memory or on RAVLT learning. The Deficit group had lower scores on both long-term memory subitems. Neuron density was also similar among patients in the Preserved and Deficit groups. IGF-1R expression was significantly higher in the granule cell layer and in CA2 in the Preserved group compared to the Deficit group, and IGF-1 expression had strong positive correlation with both the learning and long-term subitems of RAVLT. SIGNIFICANCE: Lower IGF-1 pathway activity is associated with long-term memory deficit in patients with HS type 2.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.